Overview

* Cosmos Health Q3 2025 revenue rises 38% yr/yr to a record $17.11 mln

* Adjusted EBITDA loss improves 74% yr/yr, reflecting stronger gross profitability

* Company secures $300 mln digital financing facility, enhancing financial flexibility

Outlook

* Company did not provide specific financial guidance for future quarters in press release

Result Drivers

* CORE SEGMENTS - Record-breaking performance across all core business segments, including Cana Laboratories and Decahedron in the UK, drove results

* GLOBAL EXPANSION - Expansion of proprietary brands like Sky Premium Life and C-Sept/C-Scrub contributed to growth

* GROSS MARGIN IMPROVEMENT - Gross margin expanded due to improved efficiencies and a stronger sales mix

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $17.1

Revenue mln

Q3 Gross $2.60

Profit mln

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)